| Literature DB >> 25140104 |
Ahmet Tutoğlu1, Ahmet Boyaci1, Nurefsan Boyaci2, Zekeriya Kaya3, Rifat Aridici1, Irfan Koca4.
Abstract
[Purpose] The purpose of this study was to investigate the possible relationship between joint destruction and carotid intima-media thickness in patients with rheumatoid arthritis.Entities:
Keywords: Common carotid intima-media thickness; Modified total Sharp score; Rheumatoid arthritis
Year: 2014 PMID: 25140104 PMCID: PMC4135205 DOI: 10.1589/jpts.26.1093
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Demographic and clinical data of patients and healthy controls (mean ±SD)
| Patients | Controls | |
|---|---|---|
| Age (years) | 40.55±8.00 | 38.83±6.21 |
| Male/female (number) | 10/24 | 8/23 |
| BMI (kg/m2) | 24.84±1.89 | 24.67±1.86 |
| Disease duration (months) | 63.61±69.13 | |
| PainVAS (0–10 cm) | 6.79±2.25 | |
| SJC28 | 1.14±1.70 | |
| TJC28 | 7.76±4.43 | |
| DAS28ESR | 4.89±1.22 | |
| HAQ | 1.89±0.77 | |
| ESR (mm) | 33.94±22.02 | 8.93±3.45* |
| CRP (mg/dl) | 1.50±2.56 | 0.33±0.13** |
| Rf (IU/ml) | 47.76±23.23 | |
| Total cholesterol (mg/dl) | 167.49±34.68 | 152.80±33.28 |
| LDL cholesterol (mg/dl) | 109.69±31.70 | 97.41±23.04 |
| HDL cholesterol (mg/dl) | 46.82±9.50 | 41.77±5.21** |
| Triglyceride (mg/dl) | 120.61±50.75 | 123.19±43.91 |
| TC/HDL | 3.69±1.00 | 3.68±0.80 |
* p<0.001; ** p<0.05. BMI, body mass index; CRP, C reactive protein; DAS, Disease Activity Score; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; HDL, high density lipoprotein; LDL, low-density lipoprotein; Rf, rheumatoid factor; SJC, swollen joints count; TC, total cholesterol; TJC, tender joints count; VAS, visual analog scale; tMSS, total modified Sharp score
Common carotid artery IMTs and total Modified Sharp score (mean ±SD)
| Patients | Controls | |
|---|---|---|
| Right CIMT | 0.59±0.13 | 0.50±0.06** |
| Left CIMT | 0.61±0.15 | 0.49±0.06* |
| Mean CIMT | 0.60±0.14 | 0.49±0.06* |
| tMSS | 66.17±30.79 |
* p<0.001; ** p<0.05. CIMT, Common carotid artery intima-media thickness; tMSS, total Modified Sharp Score
The relationship between patients’ mean CIMT score and demographic, clinical, and laboratory characteristics
| Pearson’ | B Regression | |
|---|---|---|
| Age (years) | 0.628* | 0.499** |
| Disease duration (months) | 1.000 | |
| PainVAS | 0.201 | |
| SJC28 | 0.307 | |
| TJC28 | 0.021 | |
| DAS28ESR | 0.249 | |
| HAQ | 0.246 | |
| ESR | 0.261 | |
| CRP | 0.429** | 0.277 |
| Rf | 0.115 | |
| Total cholesterol | 0.083 | |
| LDL cholesterol | 0.387** | 0.102 |
| HDL cholesterol | −0.265 | |
| Triglyceride | 0.410 | 0.061 |
| TC/HDL | 0.252 | |
| tMSS | 0.164 |
* p<0.001; ** p<0.05. aFrom multiple lineer regression analysis; BMI, body mass index; CRP, C-reactive protein; DAS, Disease Activity Score; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Rf, rheumatoid factor; SJC, swollen joints count; TC, total cholesterol; TJC, tender joints count; VAS, visual analog scale; tMSS, total modified Sharp score